{"gene":"NF2","run_date":"2026-06-10T05:19:52","timeline":{"discoveries":[{"year":2001,"finding":"Merlin was placed in a signaling pathway downstream of the small GTPase Rac: activated Rac induces phosphorylation of merlin and decreases its association with the cytoskeleton; merlin overexpression inhibits Rac-induced signaling in a phosphorylation-dependent manner; and Nf2-/- cells exhibit characteristics of cells expressing activated Rac alleles.","method":"Cell-based signaling assays, phosphorylation studies, Nf2-/- mouse cells, overexpression of activated Rac","journal":"Developmental cell","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods (genetic KO cells, activated Rac expression, phosphorylation assays), replicated by subsequent work","pmids":["11703924"],"is_preprint":false},{"year":2001,"finding":"p21-activated kinase (PAK), a common downstream effector of Rac and Cdc42, directly phosphorylates merlin at serine 518; this phosphorylation affects merlin activity and localization.","method":"In vivo and in vitro kinase assays, expression of activated Rac/Cdc42, PAK overexpression in mammalian cells","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro kinase assay plus in vivo assay, replicated in multiple subsequent studies","pmids":["11719502"],"is_preprint":false},{"year":2002,"finding":"PAK2 specifically phosphorylates merlin at serine 518; this phosphorylation causes dramatic relocalization of the merlin protein, demonstrated by biochemical fractionation, active/dominant-negative PAK2 mutants, immunodepletion, and phospho-directed antibodies.","method":"Biochemical fractionation, active and dominant-negative PAK2 mutants, immunodepletion, phospho-specific antibodies, wild-type and mutant merlin constructs","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — multiple orthogonal biochemical methods in a single rigorous study","pmids":["11782491"],"is_preprint":false},{"year":2003,"finding":"Nf2 deficiency in primary cells causes an inability to undergo contact-dependent growth arrest and to form stable cadherin-containing adherens junctions (AJs); merlin colocalizes and interacts with AJ components in confluent wild-type cells, indicating merlin is required for AJ assembly and contact-dependent growth arrest.","method":"Nf2-/- primary cells, colocalization imaging, co-immunoprecipitation with AJ components","journal":"Genes & development","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic KO with defined cellular phenotype plus co-IP/colocalization, replicated across labs","pmids":["12695331"],"is_preprint":false},{"year":2004,"finding":"Merlin inhibits phosphatidylinositol 3-kinase (PI3K) activity by binding to PIKE-L; wild-type merlin (but not patient-derived mutant L64P) binds PIKE-L and disrupts PIKE-L interaction with PI3K; knockdown of PIKE-L abolishes merlin's tumor-suppressive activity.","method":"Binding assays, PI3K activity assay, PIKE-L point mutant (P187L), RNA interference knockdown, cell growth assays","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro PI3K assay, mutagenesis, RNAi, single lab with multiple orthogonal methods","pmids":["15598747"],"is_preprint":false},{"year":2004,"finding":"Phosphorylation of merlin at S518 (mimicked by S518D mutation) abrogates merlin's ability to suppress cell growth and motility, whereas the non-phosphorylatable S518A mutant functions equivalently to wild-type; phosphorylation at the analogous ERM site T576 had no effect on merlin function.","method":"Doxycycline-inducible merlin mutant (S518D, S518A, T576 mutants) expression in RT4 schwannoma cells, cell growth and motility assays","journal":"Oncogene","confidence":"High","confidence_rationale":"Tier 1 / Moderate — phosphomimetic/phosphodeficient mutagenesis with functional growth and motility readouts, single lab","pmids":["14724586"],"is_preprint":false},{"year":2006,"finding":"Re-expression of merlin in NF2-deficient mesothelioma cells inhibits cell motility, spreading, and invasiveness; merlin expression attenuates FAK phosphorylation at Tyr397 and disrupts FAK interactions with Src and p85 (PI3K regulatory subunit).","method":"Merlin re-expression by adenoviral vector, siRNA knockdown in MEFs, cell invasion/motility assays, co-immunoprecipitation of FAK/Src/p85","journal":"Oncogene","confidence":"High","confidence_rationale":"Tier 2 / Moderate — reciprocal functional and biochemical assays, gain- and loss-of-function, single lab","pmids":["16652148"],"is_preprint":false},{"year":2006,"finding":"Drosophila Merlin and Expanded cooperatively regulate the steady-state levels of signaling and adhesion receptors; loss of both proteins causes upregulation of Notch at the plasma membrane due to a defect in receptor clearance/endocytosis from the cell surface.","method":"Drosophila imaginal disc genetics, pulse-chase receptor labeling in living tissues, Mer;ex double mutant analysis","journal":"Current biology : CB","confidence":"High","confidence_rationale":"Tier 2 / Strong — live-tissue pulse-chase receptor trafficking assay, genetic double mutant, replicated","pmids":["16581517"],"is_preprint":false},{"year":2007,"finding":"Merlin directly interacts with microtubules through two tubulin-binding sites (N-terminal FERM domain and C-terminal domain); merlin's intramolecular association and S518 phosphorylation regulate the merlin-tubulin interaction; merlin promotes tubulin polymerization in vitro and in vivo, and loss of merlin alters Schwann cell microtubule organization.","method":"In vitro tubulin-binding assays, merlin mutant constructs, immunofluorescence colocalization, primary Schwann cells from merlin-deficient mice","journal":"Human molecular genetics","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro reconstitution of tubulin binding/polymerization plus mutagenesis and cell biology, single lab","pmids":["17566081"],"is_preprint":false},{"year":2007,"finding":"Schwannomin/merlin interacts with NF2-interacting protein HEI10 (a cyclin B-binding cell cycle regulator); the interaction requires the alpha-helical domain of merlin and the coiled-coil domain of HEI10, and requires conformational opening of merlin; this interaction links merlin to cell cycle control machinery.","method":"Yeast two-hybrid screen, co-immunoprecipitation, domain-mapping with deletion mutants, subcellular colocalization, Schwann cell vs. schwannoma comparison","journal":"Oncogene","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — Co-IP plus domain mapping and colocalization, single lab, no direct functional rescue","pmids":["16532029"],"is_preprint":false},{"year":2009,"finding":"Loss of merlin activates integrin-dependent mTORC1 signaling and cap-dependent mRNA translation (including cyclin D1); depletion of merlin rescues mTORC1 signaling in anchorage-deprived cells; merlin-negative mesothelioma lines are rapamycin-sensitive; re-expression of merlin confers partial rapamycin resistance.","method":"shRNA knockdown, recombinant merlin re-expression, mTORC1 and cap-dependent translation assays, rapamycin sensitivity panel, xenograft models","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 / Moderate — gain- and loss-of-function with biochemical pathway readouts and pharmacological validation, single lab, multiple orthogonal methods","pmids":["19451229"],"is_preprint":false},{"year":2009,"finding":"Erbin, an epithelial-enriched protein, controls merlin tumor suppressor function by switching the functional valence of PAK2 binding: in epithelial cells, Erbin/Merlin complexes bind and inactivate GTPase-bound PAK2, preventing its phosphorylation and inactivation of merlin.","method":"Co-immunoprecipitation, TGF-β signaling assays in epithelial vs. mesenchymal cells, PAK2 kinase assays, dominant-negative constructs","journal":"Developmental cell","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — Co-IP and kinase assays, single lab, novel binding mechanism described","pmids":["19289088"],"is_preprint":false},{"year":2010,"finding":"In Nf2-deficient liver, overproliferation of liver progenitors is driven by aberrant EGFR activity; pharmacologic inhibition of EGFR blocks proliferation of Nf2-/- liver progenitors in vitro and in vivo; Merlin was found NOT to be a major regulator of YAP in liver progenitors in this context.","method":"Liver-specific conditional Nf2 knockout mouse, EGFR inhibitor treatment in vitro and in vivo, molecular pathway analysis","journal":"Genes & development","confidence":"High","confidence_rationale":"Tier 2 / Moderate — conditional KO with pharmacologic rescue, multiple readouts, single lab","pmids":["20675406"],"is_preprint":false},{"year":2012,"finding":"Rac1 controls Schwann cell myelination through NF2/merlin: Rac1 knockout reduces PAK phosphorylation and NF2/merlin phosphorylation; mutation of NF2/merlin rescues the myelin deficit in Rac1-CKO mice; cAMP levels and E-cadherin expression downstream of Rac1 are restored by NF2/merlin mutation.","method":"Rac1 conditional knockout mice, in vivo NF2 mutant rescue experiment, cAMP measurement, E-cadherin immunostaining, rolipram treatment","journal":"The Journal of neuroscience : the official journal of the Society for Neuroscience","confidence":"High","confidence_rationale":"Tier 2 / Moderate — genetic epistasis (Rac1-CKO rescued by NF2 mutation in vivo), multiple orthogonal readouts","pmids":["23197717"],"is_preprint":false},{"year":2012,"finding":"Merlin restricts the cortical distribution of the actin regulator Ezrin; in the absence of Merlin, ectopic cortical Ezrin yields mispositioned centrosomes, misoriented spindles, and aberrant epithelial architecture; in tumor cells with centrosome amplification, failure to restrict cortical Ezrin abolishes centrosome clustering, causing multipolar mitoses.","method":"Nf2-/- epithelial cells, live imaging, centrosome positioning assay, 3D organotypic cultures, spindle orientation analysis","journal":"Genes & development","confidence":"High","confidence_rationale":"Tier 2 / Moderate — genetic KO with defined cellular phenotype, live imaging, multiple functional readouts, single lab","pmids":["23249734"],"is_preprint":false},{"year":2013,"finding":"Nf2/Merlin is required upstream of Lats1/2-dependent YAP phosphorylation in the preimplantation embryo; injection of dominant-negative Nf2 causes YAP mislocalization and ectopic Cdx2 expression, rescued by Lats2 kinase overexpression; maternal-zygotic Nf2 mutant embryos fail to establish a pluripotent ICM and form excess TE.","method":"Dominant-negative Nf2 mRNA injection, Lats2 overexpression rescue, maternal-zygotic Nf2 mutant blastocysts, immunofluorescence for YAP and Cdx2","journal":"Current biology : CB","confidence":"High","confidence_rationale":"Tier 2 / Moderate — genetic epistasis (dominant-negative rescued by Lats2), maternal-zygotic KO, multiple readouts, single lab","pmids":["23791728"],"is_preprint":false},{"year":2015,"finding":"Crystal structures show that the Lats1/2-binding site on the Merlin FERM domain is physically blocked by Merlin's auto-inhibitory tail; angiomotin binding releases this auto-inhibition and promotes Merlin binding to Lats1/2; S518 phosphorylation prevents angiomotin from binding Merlin; cancer-causing mutations in the angiomotin-binding domain impair angiomotin-mediated Merlin activation.","method":"High-resolution crystal structures of Merlin FERM domain, binding assays, phospho-mimetic/deficient mutants, cancer mutation analysis","journal":"Cell research","confidence":"High","confidence_rationale":"Tier 1 / Strong — crystal structures plus mutagenesis and binding assays, mechanistic model with functional validation","pmids":["26045165"],"is_preprint":false},{"year":2015,"finding":"Merlin and Ezrin are essential components of a mechanism whereby mechanical forces associated with cell-cell junction establishment are transduced via cortical actomyosin to control lateral mobility and activity of EGFR; Merlin inhibits EGFR internalization in a contact-dependent manner requiring cortical cytoskeleton localization.","method":"Fluorescence recovery after photobleaching (FRAP), single-particle tracking, Merlin/Ezrin depletion, live imaging, cortical actomyosin perturbation","journal":"The Journal of cell biology","confidence":"High","confidence_rationale":"Tier 2 / Moderate — direct localization experiments (FRAP, SPT) tied to functional EGFR mobility/signaling, multiple orthogonal methods, single lab","pmids":["26483553"],"is_preprint":false},{"year":2015,"finding":"Merlin inhibits Wnt/β-catenin signaling by directly binding LRP6 and blocking LRP6 phosphorylation required for Wnt signal transduction; Wnt3a treatment activates PAK1 in a PIP2-dependent manner, phosphorylating Merlin at S518, causing dissociation from LRP6 and allowing LRP6 phosphorylation.","method":"Co-immunoprecipitation, LRP6 phosphorylation assays, PAK1 inhibitor/overexpression, PIP2 manipulation, NF2 patient tissue analysis","journal":"Cell death and differentiation","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — Co-IP and signaling assays, single lab","pmids":["27285107"],"is_preprint":false},{"year":2016,"finding":"Merlin triggers AMOTL1 proteasomal degradation mediated by NEDD family ubiquitin ligases through direct interaction with AMOTL1.","method":"Co-immunoprecipitation, proteasome inhibitor treatment, ubiquitination assays","journal":"Neoplasia (New York, N.Y.)","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — Co-IP and ubiquitination assay, single lab","pmids":["26806348"],"is_preprint":false},{"year":2016,"finding":"Merlin regulates NF2/Merlin-Lin28B-let-7 tumor-suppressive signaling in a Hippo-independent, cell-density-dependent manner: at high cell density, dephosphorylated Merlin sequesters Lin28B in the cytoplasm permitting pri-let-7 miRNA maturation; at low density, phosphorylated Merlin does not bind Lin28B, allowing nuclear Lin28B to inhibit let-7 maturation.","method":"Co-immunoprecipitation, cell density manipulation, phospho-mimetic merlin mutants, miRNA processing assays, Lin28B localization","journal":"Cell reports","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — Co-IP and functional miRNA assays, single lab","pmids":["26997273"],"is_preprint":false},{"year":2016,"finding":"NF2 and Lats1/2 are required for branching morphogenesis in the mouse kidney ureteric bud; removal of Nf2 or Lats1/2 causes loss of branching, rescued by loss of one copy of Yap/Taz; YAP suppresses RET signaling and tip identity downstream of NF2.","method":"Conditional knockout mice (ureteric bud lineage), genetic epistasis (Yap/Taz heterozygous rescue), mosaic analysis","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 2 / Moderate — genetic epistasis with conditional KO and heterozygous rescue, in vivo, multiple readouts","pmids":["27480037"],"is_preprint":false},{"year":2017,"finding":"In Drosophila, Merlin and Kibra activate Hippo signaling in parallel to Expanded at a spatially distinct cellular domain (medial apical cortex); Merlin and Kibra together recruit Salvador, which recruits the core kinase Hippo.","method":"Drosophila genetics, live imaging, domain-specific immunofluorescence, epistasis analysis","journal":"Developmental cell","confidence":"High","confidence_rationale":"Tier 2 / Moderate — genetic epistasis and subcellular localization with functional consequences, single lab","pmids":["28292426"],"is_preprint":false},{"year":2019,"finding":"In epithelial cells, E-cadherin-mediated intercellular contact suppresses ferroptosis by activating intracellular NF2 and Hippo signaling; YAP (when NF2/Hippo is inactive) promotes ferroptosis by upregulating ACSL4 and TFRC; NF2 genetic inactivation renders cancer cells more sensitive to ferroptosis.","method":"NF2 genetic inactivation (siRNA and KO), E-cadherin blocking antibodies, ferroptosis assays (lipid peroxidation), YAP reporter assays, orthotopic mouse model","journal":"Nature","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple genetic and pharmacologic tools, in vitro and in vivo, multiple orthogonal functional readouts","pmids":["31341276"],"is_preprint":false},{"year":2019,"finding":"NF2/Merlin regulates TEAD palmitoylation and stability in a cell-density-dependent manner; Merlin suppresses fatty acid synthase (FASN) and acetyl-CoA carboxylase (ACC) expression (involved in de novo palmitate biosynthesis), leading to TEAD depalmitoylation by APT2/ABHD17A and subsequent proteasomal degradation via E3 ligase CHIP.","method":"NF2 knockdown/overexpression, FASN/ACC expression assays, palmitoylation assays, proteasome inhibitor treatment, TEAD stability assays","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — multiple biochemical assays, single lab, novel pathway","pmids":["31043565"],"is_preprint":false},{"year":2019,"finding":"BRCA1/BARD1 ubiquitinates NF2, leading to NF2 destabilization, which turns off the Hippo pathway and stabilizes YAP1; in BRCA1-deficient cells the Hippo pathway is activated.","method":"BRCA1 knockout cells, co-immunoprecipitation, ubiquitination assay, YAP1 phosphorylation assays, YAP1 mutant (5SA) rescue","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — ubiquitination assay and KO with pathway readout, single lab","pmids":["30918126"],"is_preprint":false},{"year":2020,"finding":"NF2's lipid-binding ability is required for Hippo pathway activation in response to osmotic stress; osmotic stress induces PI(4,5)P2 plasma membrane enrichment via PIP5K family activation, allowing NF2 membrane recruitment and downstream LATS/YAP phosphorylation; NF2 mutant deficient in lipid binding cannot activate the Hippo pathway.","method":"NF2 lipid-binding mutant, PIP5K manipulation, PI(4,5)P2 measurement, LATS and YAP phosphorylation assays under osmotic stress","journal":"Genes & development","confidence":"High","confidence_rationale":"Tier 1 / Moderate — mutagenesis of lipid-binding domain with biochemical pathway readouts, lipid manipulation, single lab with multiple orthogonal methods","pmids":["32115406"],"is_preprint":false},{"year":2020,"finding":"NEDD4L-mediated ubiquitination of Merlin at lysine 396 is required to activate Merlin in the Hippo pathway; ubiquitination is promoted by S518 dephosphorylation; AMOTL1 scaffolds NEDD4L to Merlin; ubiquitinated Merlin binds Lats1 and activates Lats1; the K396R mutation or NEDD4L depletion disrupts Lats1 binding and activation and abolishes anti-mitogenic activity.","method":"Ubiquitination assays, NEDD4L overexpression/depletion, Merlin K396R mutant, Lats1 binding assays, anti-mitogenic functional assays, NF2-patient mutation analysis","journal":"EMBO reports","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in-cell ubiquitination assay with mutagenesis and functional rescue, multiple orthogonal methods, single lab","pmids":["33058421"],"is_preprint":false},{"year":2024,"finding":"In Drosophila epithelia, Merlin forms solid-like condensates at the medial apical cortex (distinct from cell junctions); condensate formation requires phosphatidylinositol-4-phosphate (PI4P)-mediated plasma membrane targeting and is antagonistically controlled by Pez and cytoskeletal tension through PI4P regulation; solid-like material properties of Merlin condensates are essential for Hippo pathway activation.","method":"Drosophila live imaging, PI4P manipulation, condensate biophysical characterization, genetic manipulation of Pez and cytoskeletal tension","journal":"Science (New York, N.Y.)","confidence":"High","confidence_rationale":"Tier 1 / Moderate — structural/biophysical condensate characterization combined with genetic manipulation and functional pathway assay, single lab","pmids":["39116228"],"is_preprint":false},{"year":2000,"finding":"Merlin isoform I and isoform II both interact with ezrin through a head-to-tail orientation (N-terminal half of one protein with C-terminal half of the other); isoform I binds only open-conformation ezrin while isoform II binds regardless of conformation; merlin homodimerization is stronger than merlin-ezrin interaction and can inhibit merlin-ezrin binding.","method":"Co-immunoprecipitation, yeast two-hybrid assays, domain-mapping experiments","journal":"Journal of neuroscience research","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — Co-IP and yeast two-hybrid with domain mapping, single lab","pmids":["11070492"],"is_preprint":false},{"year":2005,"finding":"Layilin (a cell-surface hyaluronan receptor) interacts with full-length merlin and its N-terminal FERM domain independently of phospholipids; layilin antibody can co-immunoprecipitate merlin, confirming in vivo association; both proteins show similar subcellular localization in ruffling membranes.","method":"Co-immunoprecipitation, GST-pulldown assays, immunofluorescence colocalization","journal":"Experimental cell research","confidence":"Medium","confidence_rationale":"Tier 3 / Weak — Co-IP and pulldown with colocalization, single lab","pmids":["15913605"],"is_preprint":false},{"year":2002,"finding":"Schwannomin/merlin and HRS (hepatocyte growth factor-regulated tyrosine kinase substrate) cooperatively inhibit Stat3 and Stat5 activation; a pathogenic missense mutation Q538P in schwannomin fails to bind HRS and does not inhibit Stat5 phosphorylation.","method":"Co-immunoprecipitation, STAT phosphorylation assays, schwannomin mutant (Q538P), IGF-I stimulation in human schwannoma cells","journal":"Human molecular genetics","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — Co-IP and signaling assays with mutant validation, single lab","pmids":["12444102"],"is_preprint":false},{"year":2007,"finding":"Merlin phosphorylation at S518 affects its interaction with tubulin: merlin's intramolecular association and S518 phosphorylation regulate the merlin-tubulin interaction; merlin promotes tubulin polymerization in vitro.","method":"In vitro tubulin polymerization assay, phospho-mimetic/deficient merlin mutants, primary Schwann cells from merlin-deficient mice","journal":"Human molecular genetics","confidence":"Medium","confidence_rationale":"Tier 1 / Weak — in vitro polymerization reconstitution with mutagenesis, single lab","pmids":["17566081"],"is_preprint":false},{"year":2007,"finding":"Merlin inhibits neurite outgrowth through a mechanism dependent on S518 phosphorylation and involving inactivation of Rac GTPase; overexpression of merlin in cerebellar cultures and P19 neurogenic cells decreases neurite outgrowth; merlin inhibition increases process formation.","method":"Merlin overexpression/knockdown in cerebellar cultures and P19 cells, S518 phosphorylation mutants, neurite length quantification","journal":"The Journal of neuroscience : the official journal of the Society for Neuroscience","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — gain- and loss-of-function with phospho-mutants, single lab","pmids":["20668201"],"is_preprint":false},{"year":2007,"finding":"Akt phosphorylates merlin at T230 and S315; this phosphorylation abolishes merlin's folded conformation, inhibits its association with PIKE-L, promotes merlin polyubiquitination, and leads to proteasome-mediated degradation, providing a negative feedback loop from merlin/PIKE-L/PI3K to Akt.","method":"In vitro Akt kinase assay, phospho-site mutagenesis, co-immunoprecipitation, ubiquitination assay, proteasome inhibitor treatment","journal":"Cell adhesion & migration","confidence":"Medium","confidence_rationale":"Tier 1 / Weak — kinase assay with mutagenesis and degradation assay, single lab","pmids":["19262146"],"is_preprint":false},{"year":2000,"finding":"Calpain (a calcium-dependent cysteine protease) cleaves and degrades merlin; marked calpain system activation results in merlin degradation in some schwannomas and meningiomas lacking NF2 mutations.","method":"Calpain cleavage assays, tumor tissue analysis for calpain activity and merlin levels","journal":"Neuropathology : official journal of the Japanese Society of Neuropathology","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — biochemical cleavage assay and tumor tissue analysis, single lab","pmids":["11132929"],"is_preprint":false},{"year":2015,"finding":"Merlin-deficient cells show increased dependence on FAK signaling (synthetic lethal relationship); weak cell-cell adhesions in Merlin-negative MPM cells underlie greater dependence on cell-ECM-induced FAK signaling, explaining FAK inhibitor vulnerability.","method":"Cancer cell line panel, cell-cell/ECM contact blocking antibodies, FAK inhibitor (VS-4718) sensitivity assays, xenograft models","journal":"Science translational medicine","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — pharmacologic and genetic dependency mapping, single lab","pmids":["24848258"],"is_preprint":false},{"year":2015,"finding":"Merlin suppresses FOXM1 protein stability, which plays a critical role in nuclear translocation of β-catenin; by destabilizing FOXM1, Merlin suppresses Wnt/β-catenin signaling and downstream target gene expression.","method":"Merlin overexpression/knockdown, FOXM1 protein stability assays, β-catenin nuclear localization, FOXM1 overexpression rescue","journal":"Cancer research","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — gain- and loss-of-function with rescue experiment, single lab","pmids":["26483206"],"is_preprint":false},{"year":2003,"finding":"NF2/merlin re-expression in schwannoma cells inhibits cell proliferation under serum-free conditions; merlin accelerates PDGFR internalization, inhibits PDGF-induced MAPK and PI3K signaling (pErk1/2, pAkt), and promotes PDGFR degradation.","method":"Adenoviral NF2 overexpression in HEI193 schwannoma cells, proliferation assays, receptor internalization assay, Western blotting for signaling","journal":"International journal of oncology","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — gain-of-function with receptor trafficking and signaling readouts, single lab","pmids":["14612918"],"is_preprint":false},{"year":2012,"finding":"Merlin/NF2 regulates angiogenesis in schwannomas through Rac1; loss of merlin downregulates semaphorin 3F (SEMA3F) expression through Rac1; re-introduction of SEMA3F normalized tumor blood vessels and reduced tumor burden in vivo.","method":"RNA interference, chemical inhibitors for Rac1, SEMA3F re-expression in NF2-null cells, intracranial tumor models in nude mice","journal":"Neoplasia (New York, N.Y.)","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — RNAi and rescue with in vivo validation, single lab","pmids":["22431917"],"is_preprint":false}],"current_model":"Merlin (NF2) is a FERM-domain tumor suppressor that functions at both the cell cortex and in the nucleus: at the cortex, it links membrane receptors (EGFR, PDGFR) and adhesion molecules to the cortical actomyosin cytoskeleton, restricting receptor mobility/internalization and inhibiting downstream Rac/PAK, FAK/Src, PI3K/Akt, Ras/MAPK, mTORC1, and Wnt/LRP6 signaling cascades; its activity is tightly regulated by phosphorylation at S518 (by PAK1/2, downstream of Rac/Cdc42, inactivating merlin) and dephosphorylation (activating merlin), and by ubiquitination (NEDD4L at K396, activating merlin for Hippo signaling) and Akt-mediated phosphorylation (T230/S315, promoting proteasomal degradation); merlin adopts an auto-inhibited closed conformation that is relieved by angiomotin binding to enable Lats1/2 binding and Hippo pathway activation, and at the medial apical cortex forms solid-like PI4P-dependent condensates that further activate Hippo signaling; in the nucleus, merlin directly inhibits the CRL4(DCAF1) E3 ubiquitin ligase to suppress oncogenic gene expression; collectively, these mechanisms mediate contact-dependent inhibition of proliferation, cell polarity, and suppression of tumorigenesis."},"narrative":{"mechanistic_narrative":"Merlin (NF2) is a FERM-domain tumor suppressor that couples cell-cell contact and cortical cytoskeletal organization to the restraint of mitogenic signaling and proliferation [PMID:12695331, PMID:26483553]. At the cortex, merlin associates with adherens-junction components and is required for contact-dependent growth arrest and stable junction assembly [PMID:12695331], and it transduces junctional mechanical force through cortical actomyosin to restrict the lateral mobility and internalization of EGFR [PMID:26483553]; it likewise accelerates PDGFR internalization and degradation while dampening MAPK and PI3K output [PMID:14612918], and inhibits PI3K via PIKE-L [PMID:15598747] and integrin-driven mTORC1 signaling [PMID:19451229]. Merlin activity is governed by a conformational switch and a dense phosphorylation/ubiquitination code: PAK, downstream of Rac/Cdc42, directly phosphorylates merlin at S518 to inactivate it [PMID:11719502, PMID:11782491], and the S518-phosphomimetic form fails to suppress growth and motility [PMID:14724586], whereas dephosphorylation and NEDD4L-mediated ubiquitination at K396 — scaffolded by AMOTL1 — activate merlin for Lats1 binding and anti-mitogenic function [PMID:33058421]. Structurally, an auto-inhibitory tail occludes the Lats1/2-binding surface of the FERM domain, and angiomotin binding relieves this auto-inhibition to drive Hippo pathway activation, an event blocked by S518 phosphorylation [PMID:26045165]. Merlin acts upstream of Lats1/2-dependent YAP phosphorylation to control cell fate and morphogenesis in vivo [PMID:23791728, PMID:27480037], requires lipid (PI(4,5)P2/PI4P) binding for membrane recruitment and Hippo activation [PMID:32115406], and forms PI4P-dependent solid-like condensates at the medial apical cortex essential for Hippo signaling [PMID:39116228]. Through this Hippo/YAP axis merlin also controls contact-dependent ferroptosis, with NF2 loss sensitizing cancer cells to ferroptosis [PMID:31341276]. Beyond canonical Hippo signaling, merlin restricts cortical Ezrin to ensure correct centrosome positioning and spindle orientation [PMID:23249734] and inhibits Wnt/β-catenin signaling by binding LRP6 and blocking its phosphorylation [PMID:27285107].","teleology":[{"year":2001,"claim":"Established that merlin sits in a Rac-PAK signaling axis and that its activity is controlled by phosphorylation, defining the upstream regulation of the tumor suppressor.","evidence":"Nf2-/- mouse cells, activated Rac expression and phosphorylation assays, plus in vitro/in vivo PAK kinase assays identifying S518","pmids":["11703924","11719502","11782491"],"confidence":"High","gaps":["Did not establish how S518 phosphorylation alters merlin's downstream effectors at the molecular level","Phosphatase(s) reactivating merlin not identified"]},{"year":2003,"claim":"Linked merlin to contact-dependent growth arrest by showing it is required for adherens-junction assembly, connecting the molecule to a defined cellular phenotype.","evidence":"Nf2-/- primary cells with colocalization and co-IP against AJ components","pmids":["12695331"],"confidence":"High","gaps":["Direct molecular partner within the junction not pinned down","Mechanism connecting AJ assembly to growth arrest left open"]},{"year":2004,"claim":"Connected merlin to growth-factor receptor signaling by showing it inhibits PI3K through PIKE-L and that S518 phosphorylation abrogates growth/motility suppression.","evidence":"PI3K activity assays, PIKE-L mutant and RNAi, plus inducible phosphomimetic S518D/S518A merlin in schwannoma cells","pmids":["15598747","14724586"],"confidence":"High","gaps":["Relative contribution of PIKE-L vs other effectors to tumor suppression unresolved"]},{"year":2006,"claim":"Showed merlin restrains FAK/Src/PI3K signaling and receptor trafficking, broadening its role to multiple oncogenic cascades and receptor clearance.","evidence":"Merlin re-expression in mesothelioma cells with FAK/Src/p85 co-IP; Drosophila Mer;ex double-mutant pulse-chase receptor trafficking","pmids":["16652148","16581517"],"confidence":"High","gaps":["Whether receptor clearance is the primary tumor-suppressive output not established","Direct vs indirect effect on FAK phosphorylation unclear"]},{"year":2007,"claim":"Defined merlin's interaction with the microtubule cytoskeleton, extending its cortical role to tubulin polymerization regulated by conformation and S518.","evidence":"In vitro tubulin-binding/polymerization assays, domain and phospho-mutants, merlin-deficient Schwann cells","pmids":["17566081"],"confidence":"High","gaps":["Functional consequence of merlin-microtubule binding for tumor suppression not defined"]},{"year":2009,"claim":"Connected merlin loss to integrin-driven mTORC1 activation and rapamycin sensitivity, identifying a druggable downstream dependency.","evidence":"shRNA and re-expression with mTORC1/cap-dependent translation readouts and rapamycin panel plus xenografts","pmids":["19451229"],"confidence":"High","gaps":["Molecular step linking merlin to mTORC1 not resolved"]},{"year":2010,"claim":"Demonstrated tissue-context specificity by showing Nf2-driven liver progenitor overgrowth is EGFR-driven and YAP-independent, cautioning against a single universal effector.","evidence":"Liver-specific conditional Nf2 knockout with EGFR inhibitor rescue","pmids":["20675406"],"confidence":"High","gaps":["Why YAP is dispensable here but central elsewhere is unexplained"]},{"year":2012,"claim":"Showed merlin restricts cortical Ezrin to control centrosome positioning and spindle orientation, and that Rac1-merlin signaling governs Schwann cell myelination in vivo.","evidence":"Nf2-/- epithelial cells with live imaging/spindle assays; Rac1-CKO rescued by NF2 mutation in vivo","pmids":["23249734","23197717"],"confidence":"High","gaps":["Mechanistic basis of cortical Ezrin exclusion by merlin only partly defined"]},{"year":2013,"claim":"Placed Nf2/Merlin genetically upstream of Lats1/2-YAP in cell-fate determination, cementing its role in the core Hippo pathway during development.","evidence":"Dominant-negative Nf2 with Lats2 rescue and maternal-zygotic Nf2 mutant blastocysts","pmids":["23791728"],"confidence":"High","gaps":["How merlin physically engages the Lats kinases not addressed in this study"]},{"year":2015,"claim":"Provided the structural mechanism: an auto-inhibitory tail blocks Lats1/2 binding and angiomotin relieves this auto-inhibition, with S518 phosphorylation and cancer mutations disrupting activation.","evidence":"Crystal structures of the Merlin FERM domain with binding assays, phospho- and cancer-mutant analysis","pmids":["26045165"],"confidence":"High","gaps":["In vivo dynamics of the open/closed transition not directly visualized"]},{"year":2015,"claim":"Tied junctional mechanical force to EGFR mobility/internalization via Merlin and Ezrin, and identified FAK dependency as a therapeutic vulnerability of Merlin-negative tumors.","evidence":"FRAP/single-particle tracking of EGFR with Merlin/Ezrin depletion; FAK inhibitor sensitivity in cell panels and xenografts","pmids":["26483553","24848258"],"confidence":"High","gaps":["Mechanochemical step linking cortical actomyosin to receptor confinement not fully resolved"]},{"year":2016,"claim":"Showed Merlin's Hippo control extends to in vivo organ morphogenesis and revealed Hippo-independent (Lin28B-let-7) and density-dependent outputs.","evidence":"Conditional kidney KO with Yap/Taz heterozygous rescue; co-IP and miRNA processing assays with phospho-merlin mutants","pmids":["27480037","26997273"],"confidence":"High","gaps":["Relative weight of Hippo-dependent vs -independent outputs in tumor suppression unknown"]},{"year":2019,"claim":"Connected contact-dependent NF2/Hippo signaling to ferroptosis sensitivity, identifying NF2 loss as a determinant of ferroptosis vulnerability.","evidence":"NF2 inactivation, E-cadherin blocking, ferroptosis and YAP reporter assays, orthotopic mouse model","pmids":["31341276"],"confidence":"High","gaps":["Generality across NF2-mutant tumor types not established"]},{"year":2020,"claim":"Defined lipid binding as a requirement for Merlin membrane recruitment and Hippo activation under osmotic stress, mechanistically anchoring Merlin to the plasma membrane.","evidence":"Lipid-binding mutant, PIP5K manipulation, PI(4,5)P2 measurement, LATS/YAP phosphorylation assays","pmids":["32115406"],"confidence":"High","gaps":["How lipid binding integrates with conformational opening not fully resolved"]},{"year":2020,"claim":"Resolved the activating ubiquitination event: NEDD4L modifies Merlin at K396 (AMOTL1-scaffolded, dephosphorylation-dependent) to enable Lats1 binding and anti-mitogenic activity.","evidence":"Ubiquitination assays, K396R mutant, NEDD4L depletion, Lats1 binding and functional rescue, patient mutation analysis","pmids":["33058421"],"confidence":"High","gaps":["Integration of K396 ubiquitination with the angiomotin-mediated conformational switch not directly tested"]},{"year":2024,"claim":"Showed Merlin forms PI4P-dependent solid-like condensates at the medial apical cortex whose material properties are essential for Hippo activation, adding a biophysical layer to its mechanism.","evidence":"Drosophila live imaging, PI4P manipulation, condensate biophysical characterization, Pez/tension perturbation","pmids":["39116228"],"confidence":"High","gaps":["Whether mammalian Merlin forms comparable condensates not demonstrated","Molecular composition of the condensate beyond Merlin/PI4P undefined"]},{"year":null,"claim":"How the multiple regulatory layers — conformational auto-inhibition, S518 phosphorylation, K396 ubiquitination, lipid binding, and condensate formation — are integrated into a single activation hierarchy in mammalian cells remains unresolved.","evidence":"","pmids":[],"confidence":"High","gaps":["No unified model ordering the regulatory inputs","Tissue-specific selection of effector pathways (Hippo vs EGFR vs mTORC1) not mechanistically explained"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0008092","term_label":"cytoskeletal protein binding","supporting_discovery_ids":[8,14,17,32]},{"term_id":"GO:0060089","term_label":"molecular transducer activity","supporting_discovery_ids":[16,26,27]},{"term_id":"GO:0008289","term_label":"lipid binding","supporting_discovery_ids":[26,28]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[4,18,27]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[17,26,28]},{"term_id":"GO:0005856","term_label":"cytoskeleton","supporting_discovery_ids":[0,8,14,17]},{"term_id":"GO:0005815","term_label":"microtubule organizing center","supporting_discovery_ids":[14]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[15,16,21,22,26,27]},{"term_id":"R-HSA-1500931","term_label":"Cell-Cell communication","supporting_discovery_ids":[3,17,23]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[15,21]},{"term_id":"R-HSA-5357801","term_label":"Programmed Cell Death","supporting_discovery_ids":[23]}],"complexes":[],"partners":["EZR","PAK2","AMOTL1","LATS1","PIKE-L","LRP6","NEDD4L","ERBIN"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"P35240","full_name":"Merlin","aliases":["Moesin-ezrin-radixin-like protein","Neurofibromin-2","Schwannomerlin","Schwannomin"],"length_aa":595,"mass_kda":69.7,"function":"Probable regulator of the Hippo/SWH (Sav/Wts/Hpo) signaling pathway, a signaling pathway that plays a pivotal role in tumor suppression by restricting proliferation and promoting apoptosis. Along with WWC1 can synergistically induce the phosphorylation of LATS1 and LATS2 and can probably function in the regulation of the Hippo/SWH (Sav/Wts/Hpo) signaling pathway. May act as a membrane stabilizing protein. May inhibit PI3 kinase by binding to AGAP2 and impairing its stimulating activity. Suppresses cell proliferation and tumorigenesis by inhibiting the CUL4A-RBX1-DDB1-VprBP/DCAF1 E3 ubiquitin-protein ligase complex","subcellular_location":"Nucleus; Cell projection, filopodium membrane; Cell projection, ruffle membrane; Cytoplasm, perinuclear region; Cytoplasmic granule; Cytoplasm, cytoskeleton","url":"https://www.uniprot.org/uniprotkb/P35240/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/NF2","classification":"Not Classified","n_dependent_lines":46,"n_total_lines":1208,"dependency_fraction":0.0380794701986755},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/NF2","total_profiled":1310},"omim":[{"mim_id":"620871","title":"DNA DAMAGE-INDUCIBLE 1 HOMOLOG 2; DDI2","url":"https://www.omim.org/entry/620871"},{"mim_id":"619206","title":"SCHWANNOMIN-INTERACTING PROTEIN 1; SCHIP1","url":"https://www.omim.org/entry/619206"},{"mim_id":"618843","title":"LAYILIN; LAYN","url":"https://www.omim.org/entry/618843"},{"mim_id":"615670","title":"SCHWANNOMATOSIS 2; SWN2","url":"https://www.omim.org/entry/615670"},{"mim_id":"614647","title":"COENZYME Q6, MONOOXYGENASE; COQ6","url":"https://www.omim.org/entry/614647"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Enhanced","locations":[{"location":"Plasma membrane","reliability":"Enhanced"},{"location":"Nucleoplasm","reliability":"Additional"},{"location":"Cytosol","reliability":"Additional"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/NF2"},"hgnc":{"alias_symbol":["merlin","ACN","SCH","BANF","merlin-1"],"prev_symbol":[]},"alphafold":{"accession":"P35240","domains":[{"cath_id":"3.10.20.90","chopping":"20-97","consensus_level":"medium","plddt":94.3392,"start":20,"end":97},{"cath_id":"1.20.80.10","chopping":"111-211","consensus_level":"medium","plddt":96.4468,"start":111,"end":211},{"cath_id":"2.30.29.30","chopping":"219-312","consensus_level":"medium","plddt":92.2007,"start":219,"end":312},{"cath_id":"1.20.120","chopping":"317-415_423-476","consensus_level":"medium","plddt":89.7465,"start":317,"end":476}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P35240","model_url":"https://alphafold.ebi.ac.uk/files/AF-P35240-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P35240-F1-predicted_aligned_error_v6.png","plddt_mean":87.38},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=NF2","jax_strain_url":"https://www.jax.org/strain/search?query=NF2"},"sequence":{"accession":"P35240","fasta_url":"https://rest.uniprot.org/uniprotkb/P35240.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P35240/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P35240"}},"corpus_meta":[{"pmid":"12154370","id":"PMC_12154370","title":"ERM proteins and merlin: integrators at the cell cortex.","date":"2002","source":"Nature reviews. Molecular cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/12154370","citation_count":1121,"is_preprint":false},{"pmid":"31341276","id":"PMC_31341276","title":"Intercellular interaction dictates cancer cell ferroptosis via NF2-YAP signalling.","date":"2019","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/31341276","citation_count":918,"is_preprint":false},{"pmid":"23348505","id":"PMC_23348505","title":"Genomic analysis of non-NF2 meningiomas reveals mutations in TRAF7, KLF4, AKT1, and SMO.","date":"2013","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/23348505","citation_count":721,"is_preprint":false},{"pmid":"20663931","id":"PMC_20663931","title":"Dinaciclib (SCH 727965), a novel and potent cyclin-dependent kinase inhibitor.","date":"2010","source":"Molecular cancer therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/20663931","citation_count":458,"is_preprint":false},{"pmid":"19545378","id":"PMC_19545378","title":"Neurofibromatosis type 2 (NF2): a clinical and molecular review.","date":"2009","source":"Orphanet journal of rare diseases","url":"https://pubmed.ncbi.nlm.nih.gov/19545378","citation_count":360,"is_preprint":false},{"pmid":"25893302","id":"PMC_25893302","title":"Role of Merlin/NF2 inactivation in tumor biology.","date":"2015","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/25893302","citation_count":346,"is_preprint":false},{"pmid":"11703924","id":"PMC_11703924","title":"The Nf2 tumor suppressor, merlin, functions in Rac-dependent signaling.","date":"2001","source":"Developmental cell","url":"https://pubmed.ncbi.nlm.nih.gov/11703924","citation_count":286,"is_preprint":false},{"pmid":"12695331","id":"PMC_12695331","title":"NF2 deficiency promotes tumorigenesis and metastasis by destabilizing adherens junctions.","date":"2003","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/12695331","citation_count":255,"is_preprint":false},{"pmid":"20675406","id":"PMC_20675406","title":"Nf2/Merlin controls progenitor homeostasis and tumorigenesis in the liver.","date":"2010","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/20675406","citation_count":223,"is_preprint":false},{"pmid":"11719502","id":"PMC_11719502","title":"p21-activated kinase links Rac/Cdc42 signaling to merlin.","date":"2001","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11719502","citation_count":218,"is_preprint":false},{"pmid":"24848258","id":"PMC_24848258","title":"Merlin deficiency predicts FAK inhibitor sensitivity: a synthetic lethal relationship.","date":"2014","source":"Science translational medicine","url":"https://pubmed.ncbi.nlm.nih.gov/24848258","citation_count":215,"is_preprint":false},{"pmid":"8755919","id":"PMC_8755919","title":"Type of mutation in the neurofibromatosis type 2 gene (NF2) frequently determines severity of disease.","date":"1996","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/8755919","citation_count":212,"is_preprint":false},{"pmid":"16204178","id":"PMC_16204178","title":"Membrane organization and tumorigenesis--the NF2 tumor suppressor, Merlin.","date":"2005","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/16204178","citation_count":206,"is_preprint":false},{"pmid":"11782491","id":"PMC_11782491","title":"Merlin phosphorylation by p21-activated kinase 2 and effects of phosphorylation on merlin localization.","date":"2002","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11782491","citation_count":192,"is_preprint":false},{"pmid":"8012353","id":"PMC_8012353","title":"Exon scanning for mutation of the NF2 gene in schwannomas.","date":"1994","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/8012353","citation_count":190,"is_preprint":false},{"pmid":"23791728","id":"PMC_23791728","title":"The Hippo pathway member Nf2 is required for inner cell mass specification.","date":"2013","source":"Current biology : CB","url":"https://pubmed.ncbi.nlm.nih.gov/23791728","citation_count":172,"is_preprint":false},{"pmid":"16581517","id":"PMC_16581517","title":"The tumor suppressors Merlin and Expanded function cooperatively to modulate receptor endocytosis and signaling.","date":"2006","source":"Current biology : CB","url":"https://pubmed.ncbi.nlm.nih.gov/16581517","citation_count":170,"is_preprint":false},{"pmid":"19345106","id":"PMC_19345106","title":"Merlin and the ERM proteins--regulators of receptor distribution and signaling at the cell cortex.","date":"2009","source":"Trends in cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/19345106","citation_count":160,"is_preprint":false},{"pmid":"24726726","id":"PMC_24726726","title":"Molecular insights into NF2/Merlin tumor suppressor function.","date":"2014","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/24726726","citation_count":154,"is_preprint":false},{"pmid":"18285426","id":"PMC_18285426","title":"Molecular characterisation of SMARCB1 and NF2 in familial and sporadic schwannomatosis.","date":"2008","source":"Journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/18285426","citation_count":152,"is_preprint":false},{"pmid":"19451229","id":"PMC_19451229","title":"Loss of the tumor suppressor gene NF2, encoding merlin, constitutively activates integrin-dependent mTORC1 signaling.","date":"2009","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/19451229","citation_count":141,"is_preprint":false},{"pmid":"16652148","id":"PMC_16652148","title":"Re-expression of the tumor suppressor NF2/merlin inhibits invasiveness in mesothelioma cells and negatively regulates FAK.","date":"2006","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/16652148","citation_count":141,"is_preprint":false},{"pmid":"7911002","id":"PMC_7911002","title":"Frequent NF2 gene transcript mutations in sporadic meningiomas and vestibular schwannomas.","date":"1994","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/7911002","citation_count":129,"is_preprint":false},{"pmid":"15598747","id":"PMC_15598747","title":"Neurofibromatosis 2 (NF2) tumor suppressor merlin inhibits phosphatidylinositol 3-kinase through binding to PIKE-L.","date":"2004","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/15598747","citation_count":124,"is_preprint":false},{"pmid":"26045165","id":"PMC_26045165","title":"Angiomotin binding-induced activation of Merlin/NF2 in the Hippo pathway.","date":"2015","source":"Cell research","url":"https://pubmed.ncbi.nlm.nih.gov/26045165","citation_count":120,"is_preprint":false},{"pmid":"8089100","id":"PMC_8089100","title":"An anti-Ras function of neurofibromatosis type 2 gene product (NF2/Merlin).","date":"1994","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8089100","citation_count":119,"is_preprint":false},{"pmid":"22482125","id":"PMC_22482125","title":"Merlin: a tumour suppressor with functions at the cell cortex and in the nucleus.","date":"2012","source":"EMBO reports","url":"https://pubmed.ncbi.nlm.nih.gov/22482125","citation_count":109,"is_preprint":false},{"pmid":"17971776","id":"PMC_17971776","title":"Nf2/Merlin: a coordinator of receptor signalling and intercellular contact.","date":"2007","source":"British journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/17971776","citation_count":100,"is_preprint":false},{"pmid":"2105641","id":"PMC_2105641","title":"Flanking markers bracket the neurofibromatosis type 2 (NF2) gene on chromosome 22.","date":"1990","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/2105641","citation_count":98,"is_preprint":false},{"pmid":"28292426","id":"PMC_28292426","title":"Kibra and Merlin Activate the Hippo Pathway Spatially Distinct from and Independent of Expanded.","date":"2017","source":"Developmental cell","url":"https://pubmed.ncbi.nlm.nih.gov/28292426","citation_count":96,"is_preprint":false},{"pmid":"17442573","id":"PMC_17442573","title":"Shedding light on Merlin's wizardry.","date":"2007","source":"Trends in cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/17442573","citation_count":93,"is_preprint":false},{"pmid":"29587439","id":"PMC_29587439","title":"NF2/Merlin Inactivation and Potential Therapeutic Targets in Mesothelioma.","date":"2018","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/29587439","citation_count":90,"is_preprint":false},{"pmid":"10214350","id":"PMC_10214350","title":"Merlin: the neurofibromatosis 2 tumor suppressor.","date":"1999","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/10214350","citation_count":89,"is_preprint":false},{"pmid":"33445724","id":"PMC_33445724","title":"Neurofibromatosis Type 2 (NF2) and the Implications for Vestibular Schwannoma and Meningioma Pathogenesis.","date":"2021","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/33445724","citation_count":86,"is_preprint":false},{"pmid":"33087175","id":"PMC_33087175","title":"Distinct genomic subclasses of high-grade/progressive meningiomas: NF2-associated, NF2-exclusive, and NF2-agnostic.","date":"2020","source":"Acta neuropathologica communications","url":"https://pubmed.ncbi.nlm.nih.gov/33087175","citation_count":85,"is_preprint":false},{"pmid":"14724586","id":"PMC_14724586","title":"Effect of merlin phosphorylation on neurofibromatosis 2 (NF2) gene function.","date":"2004","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/14724586","citation_count":82,"is_preprint":false},{"pmid":"28824165","id":"PMC_28824165","title":"Timing of Smarcb1 and Nf2 inactivation determines schwannoma versus rhabdoid tumor development.","date":"2017","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/28824165","citation_count":79,"is_preprint":false},{"pmid":"14612918","id":"PMC_14612918","title":"Overexpression of the NF2 gene inhibits schwannoma cell proliferation through promoting PDGFR degradation.","date":"2003","source":"International journal of oncology","url":"https://pubmed.ncbi.nlm.nih.gov/14612918","citation_count":78,"is_preprint":false},{"pmid":"31043565","id":"PMC_31043565","title":"Cell contact and Nf2/Merlin-dependent regulation of TEAD palmitoylation and activity.","date":"2019","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/31043565","citation_count":77,"is_preprint":false},{"pmid":"33984142","id":"PMC_33984142","title":"MEF2C silencing downregulates NF2 and E-cadherin and enhances Erastin-induced ferroptosis in meningioma.","date":"2021","source":"Neuro-oncology","url":"https://pubmed.ncbi.nlm.nih.gov/33984142","citation_count":67,"is_preprint":false},{"pmid":"17980164","id":"PMC_17980164","title":"The merlin interacting proteins reveal multiple targets for NF2 therapy.","date":"2007","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/17980164","citation_count":67,"is_preprint":false},{"pmid":"9817927","id":"PMC_9817927","title":"NF2 gene in neurofibromatosis type 2 patients.","date":"1998","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/9817927","citation_count":66,"is_preprint":false},{"pmid":"21615608","id":"PMC_21615608","title":"Inactivation of Merlin in malignant mesothelioma cells and the Hippo signaling cascade dysregulation.","date":"2011","source":"Pathology international","url":"https://pubmed.ncbi.nlm.nih.gov/21615608","citation_count":65,"is_preprint":false},{"pmid":"31652973","id":"PMC_31652973","title":"The Role of Merlin/NF2 Loss in Meningioma Biology.","date":"2019","source":"Cancers","url":"https://pubmed.ncbi.nlm.nih.gov/31652973","citation_count":61,"is_preprint":false},{"pmid":"15609345","id":"PMC_15609345","title":"Genetic and epigenetic alteration of the NF2 gene in sporadic meningiomas.","date":"2005","source":"Genes, chromosomes & cancer","url":"https://pubmed.ncbi.nlm.nih.gov/15609345","citation_count":61,"is_preprint":false},{"pmid":"10048137","id":"PMC_10048137","title":"Induction of oxidative stress in rat brain by acrylonitrile (ACN).","date":"1998","source":"Toxicological sciences : an official journal of the Society of Toxicology","url":"https://pubmed.ncbi.nlm.nih.gov/10048137","citation_count":58,"is_preprint":false},{"pmid":"19898272","id":"PMC_19898272","title":"The neurofibromatoses. Part 2: NF2 and schwannomatosis.","date":"2009","source":"Reviews in neurological diseases","url":"https://pubmed.ncbi.nlm.nih.gov/19898272","citation_count":57,"is_preprint":false},{"pmid":"23197717","id":"PMC_23197717","title":"Rac1 controls Schwann cell myelination through cAMP and NF2/merlin.","date":"2012","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/23197717","citation_count":56,"is_preprint":false},{"pmid":"23931824","id":"PMC_23931824","title":"Neurofibromatosis type 2 (NF2): diagnosis and management.","date":"2013","source":"Handbook of clinical neurology","url":"https://pubmed.ncbi.nlm.nih.gov/23931824","citation_count":55,"is_preprint":false},{"pmid":"32115406","id":"PMC_32115406","title":"Critical roles of phosphoinositides and NF2 in Hippo pathway regulation.","date":"2020","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/32115406","citation_count":54,"is_preprint":false},{"pmid":"23249734","id":"PMC_23249734","title":"Merlin/ERM proteins establish cortical asymmetry and centrosome position.","date":"2012","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/23249734","citation_count":54,"is_preprint":false},{"pmid":"27480037","id":"PMC_27480037","title":"A critical role for NF2 and the Hippo pathway in branching morphogenesis.","date":"2016","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/27480037","citation_count":53,"is_preprint":false},{"pmid":"26483553","id":"PMC_26483553","title":"NF2/Merlin mediates contact-dependent inhibition of EGFR mobility and internalization via cortical actomyosin.","date":"2015","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/26483553","citation_count":52,"is_preprint":false},{"pmid":"26360373","id":"PMC_26360373","title":"Alterations in the NF2/LATS1/LATS2/YAP Pathway in Schwannomas.","date":"2015","source":"Journal of neuropathology and experimental neurology","url":"https://pubmed.ncbi.nlm.nih.gov/26360373","citation_count":52,"is_preprint":false},{"pmid":"15913605","id":"PMC_15913605","title":"Layilin, a cell surface hyaluronan receptor, interacts with merlin and radixin.","date":"2005","source":"Experimental cell research","url":"https://pubmed.ncbi.nlm.nih.gov/15913605","citation_count":51,"is_preprint":false},{"pmid":"24786638","id":"PMC_24786638","title":"Analyses of merlin/NF2 connection to FAK inhibitor responsiveness in serous ovarian cancer.","date":"2014","source":"Gynecologic oncology","url":"https://pubmed.ncbi.nlm.nih.gov/24786638","citation_count":49,"is_preprint":false},{"pmid":"14566860","id":"PMC_14566860","title":"NF2: the wizardry of merlin.","date":"2003","source":"Genes, chromosomes & cancer","url":"https://pubmed.ncbi.nlm.nih.gov/14566860","citation_count":48,"is_preprint":false},{"pmid":"22595235","id":"PMC_22595235","title":"Merlin, a multi-suppressor from cell membrane to the nucleus.","date":"2012","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/22595235","citation_count":48,"is_preprint":false},{"pmid":"26483206","id":"PMC_26483206","title":"Merlin/NF2 Suppresses Pancreatic Tumor Growth and Metastasis by Attenuating the FOXM1-Mediated Wnt/β-Catenin Signaling.","date":"2015","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/26483206","citation_count":48,"is_preprint":false},{"pmid":"17360635","id":"PMC_17360635","title":"The Nf2 tumor suppressor regulates cell-cell adhesion during tissue fusion.","date":"2007","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/17360635","citation_count":46,"is_preprint":false},{"pmid":"8012352","id":"PMC_8012352","title":"The murine NF2 homologue encodes a highly conserved merlin protein with alternative forms.","date":"1994","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/8012352","citation_count":45,"is_preprint":false},{"pmid":"23666797","id":"PMC_23666797","title":"Merlin, the NF2 gene product.","date":"2013","source":"Pathology oncology research : POR","url":"https://pubmed.ncbi.nlm.nih.gov/23666797","citation_count":44,"is_preprint":false},{"pmid":"24393766","id":"PMC_24393766","title":"NF2/merlin in hereditary neurofibromatosis 2 versus cancer: biologic mechanisms and clinical associations.","date":"2014","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/24393766","citation_count":44,"is_preprint":false},{"pmid":"11070492","id":"PMC_11070492","title":"Interaction between two isoforms of the NF2 tumor suppressor protein, merlin, and between merlin and ezrin, suggests modulation of ERM proteins by merlin.","date":"2000","source":"Journal of neuroscience research","url":"https://pubmed.ncbi.nlm.nih.gov/11070492","citation_count":44,"is_preprint":false},{"pmid":"22431917","id":"PMC_22431917","title":"Merlin/NF2 regulates angiogenesis in schwannomas through a Rac1/semaphorin 3F-dependent mechanism.","date":"2012","source":"Neoplasia (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/22431917","citation_count":43,"is_preprint":false},{"pmid":"12444102","id":"PMC_12444102","title":"Neurofibromatosis 2 (NF2) tumor suppressor schwannomin and its interacting protein HRS regulate STAT signaling.","date":"2002","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/12444102","citation_count":42,"is_preprint":false},{"pmid":"7795605","id":"PMC_7795605","title":"Expression of the neurofibromatosis 2 (NF2) gene isoforms during rat embryonic development.","date":"1995","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/7795605","citation_count":42,"is_preprint":false},{"pmid":"18682243","id":"PMC_18682243","title":"Nf2/merlin regulates hematopoietic stem cell behavior by altering microenvironmental architecture.","date":"2008","source":"Cell stem cell","url":"https://pubmed.ncbi.nlm.nih.gov/18682243","citation_count":41,"is_preprint":false},{"pmid":"19289088","id":"PMC_19289088","title":"Erbin and the NF2 tumor suppressor Merlin cooperatively regulate cell-type-specific activation of PAK2 by TGF-beta.","date":"2009","source":"Developmental cell","url":"https://pubmed.ncbi.nlm.nih.gov/19289088","citation_count":41,"is_preprint":false},{"pmid":"27958595","id":"PMC_27958595","title":"Childhood neurofibromatosis type 2 (NF2) and related disorders: from bench to bedside and biologically targeted therapies.","date":"2016","source":"Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale","url":"https://pubmed.ncbi.nlm.nih.gov/27958595","citation_count":39,"is_preprint":false},{"pmid":"22295085","id":"PMC_22295085","title":"Genetic and epigenetic alterations of the NF2 gene in sporadic vestibular schwannomas.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/22295085","citation_count":39,"is_preprint":false},{"pmid":"26923924","id":"PMC_26923924","title":"Neurofibromatosis 2 (NF2) controls the invasiveness of glioblastoma through YAP-dependent expression of CYR61/CCN1 and miR-296-3p.","date":"2016","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/26923924","citation_count":39,"is_preprint":false},{"pmid":"32299434","id":"PMC_32299434","title":"Merlin regulates signaling events at the nexus of development and cancer.","date":"2020","source":"Cell communication and signaling : CCS","url":"https://pubmed.ncbi.nlm.nih.gov/32299434","citation_count":38,"is_preprint":false},{"pmid":"17566081","id":"PMC_17566081","title":"The tumor suppressor merlin interacts with microtubules and modulates Schwann cell microtubule cytoskeleton.","date":"2007","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/17566081","citation_count":37,"is_preprint":false},{"pmid":"27363027","id":"PMC_27363027","title":"Crizotinib inhibits NF2-associated schwannoma through inhibition of focal adhesion kinase 1.","date":"2016","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/27363027","citation_count":36,"is_preprint":false},{"pmid":"27285107","id":"PMC_27285107","title":"Merlin inhibits Wnt/β-catenin signaling by blocking LRP6 phosphorylation.","date":"2016","source":"Cell death and differentiation","url":"https://pubmed.ncbi.nlm.nih.gov/27285107","citation_count":33,"is_preprint":false},{"pmid":"28427224","id":"PMC_28427224","title":"Ponatinib promotes a G1 cell-cycle arrest of merlin/NF2-deficient human schwann cells.","date":"2017","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/28427224","citation_count":32,"is_preprint":false},{"pmid":"26806348","id":"PMC_26806348","title":"AMOTL1 Promotes Breast Cancer Progression and Is Antagonized by Merlin.","date":"2016","source":"Neoplasia (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/26806348","citation_count":32,"is_preprint":false},{"pmid":"22750751","id":"PMC_22750751","title":"Merlin: the wizard requires protein stability to function as a tumor suppressor.","date":"2012","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/22750751","citation_count":29,"is_preprint":false},{"pmid":"11132929","id":"PMC_11132929","title":"Calpain-dependent proteolysis of NF2 protein: involvement in schwannomas and meningiomas.","date":"2000","source":"Neuropathology : official journal of the Japanese Society of Neuropathology","url":"https://pubmed.ncbi.nlm.nih.gov/11132929","citation_count":27,"is_preprint":false},{"pmid":"29249622","id":"PMC_29249622","title":"Differential Expression of NF2 in Neuroepithelial Compartments Is Necessary for Mammalian Eye Development.","date":"2017","source":"Developmental cell","url":"https://pubmed.ncbi.nlm.nih.gov/29249622","citation_count":26,"is_preprint":false},{"pmid":"17085966","id":"PMC_17085966","title":"Angucyclines Sch 47554 and Sch 47555 from Streptomyces sp. SCC-2136: cloning, sequencing, and characterization.","date":"2006","source":"Molecules and cells","url":"https://pubmed.ncbi.nlm.nih.gov/17085966","citation_count":26,"is_preprint":false},{"pmid":"33058421","id":"PMC_33058421","title":"NEDD4L-mediated Merlin ubiquitination facilitates Hippo pathway activation.","date":"2020","source":"EMBO reports","url":"https://pubmed.ncbi.nlm.nih.gov/33058421","citation_count":25,"is_preprint":false},{"pmid":"26997273","id":"PMC_26997273","title":"Merlin/NF2-Lin28B-let-7 Is a Tumor-Suppressive Pathway that Is Cell-Density Dependent and Hippo Independent.","date":"2016","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/26997273","citation_count":25,"is_preprint":false},{"pmid":"37180489","id":"PMC_37180489","title":"NF2 alteration in mesothelioma.","date":"2023","source":"Frontiers in toxicology","url":"https://pubmed.ncbi.nlm.nih.gov/37180489","citation_count":24,"is_preprint":false},{"pmid":"23267122","id":"PMC_23267122","title":"Neurofibromatosis type 2 protein, NF2: an uncoventional cell cycle regulator.","date":"2013","source":"Anticancer research","url":"https://pubmed.ncbi.nlm.nih.gov/23267122","citation_count":24,"is_preprint":false},{"pmid":"19262146","id":"PMC_19262146","title":"Phosphorylation of merlin regulates its stability and tumor suppressive activity.","date":"2007","source":"Cell adhesion & migration","url":"https://pubmed.ncbi.nlm.nih.gov/19262146","citation_count":24,"is_preprint":false},{"pmid":"25043298","id":"PMC_25043298","title":"Oncogenic role of Merlin/NF2 in glioblastoma.","date":"2014","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/25043298","citation_count":24,"is_preprint":false},{"pmid":"16532029","id":"PMC_16532029","title":"A functional association between merlin and HEI10, a cell cycle regulator.","date":"2006","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/16532029","citation_count":24,"is_preprint":false},{"pmid":"14562282","id":"PMC_14562282","title":"Chromosome 22q alterations and expression of the NF2 gene product, merlin, in gastrointestinal stromal tumors.","date":"2003","source":"Human pathology","url":"https://pubmed.ncbi.nlm.nih.gov/14562282","citation_count":24,"is_preprint":false},{"pmid":"20668201","id":"PMC_20668201","title":"Merlin inhibits neurite outgrowth in the CNS.","date":"2010","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/20668201","citation_count":24,"is_preprint":false},{"pmid":"32244314","id":"PMC_32244314","title":"Therapy of Sporadic and NF2-Related Vestibular Schwannoma.","date":"2020","source":"Cancers","url":"https://pubmed.ncbi.nlm.nih.gov/32244314","citation_count":23,"is_preprint":false},{"pmid":"38879686","id":"PMC_38879686","title":"NF2: An underestimated player in cancer metabolic reprogramming and tumor immunity.","date":"2024","source":"NPJ precision oncology","url":"https://pubmed.ncbi.nlm.nih.gov/38879686","citation_count":22,"is_preprint":false},{"pmid":"27289045","id":"PMC_27289045","title":"Merlin, the product of NF2 gene, is associated with aromatase expression and estrogen formation in human liver tissues and liver cancer cells.","date":"2016","source":"The Journal of steroid biochemistry and molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/27289045","citation_count":22,"is_preprint":false},{"pmid":"21182951","id":"PMC_21182951","title":"Schwannomin/merlin promotes Schwann cell elongation and influences myelin segment length.","date":"2010","source":"Molecular and cellular neurosciences","url":"https://pubmed.ncbi.nlm.nih.gov/21182951","citation_count":22,"is_preprint":false},{"pmid":"25012216","id":"PMC_25012216","title":"A neuronal function of the tumor suppressor protein merlin.","date":"2014","source":"Acta neuropathologica communications","url":"https://pubmed.ncbi.nlm.nih.gov/25012216","citation_count":22,"is_preprint":false},{"pmid":"27345717","id":"PMC_27345717","title":"Merlin, a regulator of Hippo signaling, regulates Wnt/β-catenin signaling.","date":"2016","source":"BMB reports","url":"https://pubmed.ncbi.nlm.nih.gov/27345717","citation_count":22,"is_preprint":false},{"pmid":"30918126","id":"PMC_30918126","title":"BRCA1/BARD1-dependent ubiquitination of NF2 regulates Hippo-YAP1 signaling.","date":"2019","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/30918126","citation_count":21,"is_preprint":false},{"pmid":"11996787","id":"PMC_11996787","title":"Analysis of the NF2 gene in oligodendrogliomas and ependymomas.","date":"2002","source":"Cancer genetics and cytogenetics","url":"https://pubmed.ncbi.nlm.nih.gov/11996787","citation_count":21,"is_preprint":false},{"pmid":"39116228","id":"PMC_39116228","title":"PI4P-mediated solid-like Merlin condensates orchestrate Hippo pathway regulation.","date":"2024","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/39116228","citation_count":20,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":44548,"output_tokens":9376,"usd":0.137142,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":19464,"output_tokens":4939,"usd":0.110397,"stage2_stop_reason":"end_turn"},"total_usd":0.247539,"stage1_batch_id":"msgbatch_013a8chtv3AWyTqv4z4sEF4C","stage2_batch_id":"msgbatch_01AHsuW63vinsvuTgzmQ3n62","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2001,\n      \"finding\": \"Merlin was placed in a signaling pathway downstream of the small GTPase Rac: activated Rac induces phosphorylation of merlin and decreases its association with the cytoskeleton; merlin overexpression inhibits Rac-induced signaling in a phosphorylation-dependent manner; and Nf2-/- cells exhibit characteristics of cells expressing activated Rac alleles.\",\n      \"method\": \"Cell-based signaling assays, phosphorylation studies, Nf2-/- mouse cells, overexpression of activated Rac\",\n      \"journal\": \"Developmental cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods (genetic KO cells, activated Rac expression, phosphorylation assays), replicated by subsequent work\",\n      \"pmids\": [\"11703924\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"p21-activated kinase (PAK), a common downstream effector of Rac and Cdc42, directly phosphorylates merlin at serine 518; this phosphorylation affects merlin activity and localization.\",\n      \"method\": \"In vivo and in vitro kinase assays, expression of activated Rac/Cdc42, PAK overexpression in mammalian cells\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro kinase assay plus in vivo assay, replicated in multiple subsequent studies\",\n      \"pmids\": [\"11719502\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"PAK2 specifically phosphorylates merlin at serine 518; this phosphorylation causes dramatic relocalization of the merlin protein, demonstrated by biochemical fractionation, active/dominant-negative PAK2 mutants, immunodepletion, and phospho-directed antibodies.\",\n      \"method\": \"Biochemical fractionation, active and dominant-negative PAK2 mutants, immunodepletion, phospho-specific antibodies, wild-type and mutant merlin constructs\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — multiple orthogonal biochemical methods in a single rigorous study\",\n      \"pmids\": [\"11782491\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Nf2 deficiency in primary cells causes an inability to undergo contact-dependent growth arrest and to form stable cadherin-containing adherens junctions (AJs); merlin colocalizes and interacts with AJ components in confluent wild-type cells, indicating merlin is required for AJ assembly and contact-dependent growth arrest.\",\n      \"method\": \"Nf2-/- primary cells, colocalization imaging, co-immunoprecipitation with AJ components\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic KO with defined cellular phenotype plus co-IP/colocalization, replicated across labs\",\n      \"pmids\": [\"12695331\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Merlin inhibits phosphatidylinositol 3-kinase (PI3K) activity by binding to PIKE-L; wild-type merlin (but not patient-derived mutant L64P) binds PIKE-L and disrupts PIKE-L interaction with PI3K; knockdown of PIKE-L abolishes merlin's tumor-suppressive activity.\",\n      \"method\": \"Binding assays, PI3K activity assay, PIKE-L point mutant (P187L), RNA interference knockdown, cell growth assays\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro PI3K assay, mutagenesis, RNAi, single lab with multiple orthogonal methods\",\n      \"pmids\": [\"15598747\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Phosphorylation of merlin at S518 (mimicked by S518D mutation) abrogates merlin's ability to suppress cell growth and motility, whereas the non-phosphorylatable S518A mutant functions equivalently to wild-type; phosphorylation at the analogous ERM site T576 had no effect on merlin function.\",\n      \"method\": \"Doxycycline-inducible merlin mutant (S518D, S518A, T576 mutants) expression in RT4 schwannoma cells, cell growth and motility assays\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — phosphomimetic/phosphodeficient mutagenesis with functional growth and motility readouts, single lab\",\n      \"pmids\": [\"14724586\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Re-expression of merlin in NF2-deficient mesothelioma cells inhibits cell motility, spreading, and invasiveness; merlin expression attenuates FAK phosphorylation at Tyr397 and disrupts FAK interactions with Src and p85 (PI3K regulatory subunit).\",\n      \"method\": \"Merlin re-expression by adenoviral vector, siRNA knockdown in MEFs, cell invasion/motility assays, co-immunoprecipitation of FAK/Src/p85\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal functional and biochemical assays, gain- and loss-of-function, single lab\",\n      \"pmids\": [\"16652148\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Drosophila Merlin and Expanded cooperatively regulate the steady-state levels of signaling and adhesion receptors; loss of both proteins causes upregulation of Notch at the plasma membrane due to a defect in receptor clearance/endocytosis from the cell surface.\",\n      \"method\": \"Drosophila imaginal disc genetics, pulse-chase receptor labeling in living tissues, Mer;ex double mutant analysis\",\n      \"journal\": \"Current biology : CB\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — live-tissue pulse-chase receptor trafficking assay, genetic double mutant, replicated\",\n      \"pmids\": [\"16581517\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Merlin directly interacts with microtubules through two tubulin-binding sites (N-terminal FERM domain and C-terminal domain); merlin's intramolecular association and S518 phosphorylation regulate the merlin-tubulin interaction; merlin promotes tubulin polymerization in vitro and in vivo, and loss of merlin alters Schwann cell microtubule organization.\",\n      \"method\": \"In vitro tubulin-binding assays, merlin mutant constructs, immunofluorescence colocalization, primary Schwann cells from merlin-deficient mice\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro reconstitution of tubulin binding/polymerization plus mutagenesis and cell biology, single lab\",\n      \"pmids\": [\"17566081\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Schwannomin/merlin interacts with NF2-interacting protein HEI10 (a cyclin B-binding cell cycle regulator); the interaction requires the alpha-helical domain of merlin and the coiled-coil domain of HEI10, and requires conformational opening of merlin; this interaction links merlin to cell cycle control machinery.\",\n      \"method\": \"Yeast two-hybrid screen, co-immunoprecipitation, domain-mapping with deletion mutants, subcellular colocalization, Schwann cell vs. schwannoma comparison\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — Co-IP plus domain mapping and colocalization, single lab, no direct functional rescue\",\n      \"pmids\": [\"16532029\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Loss of merlin activates integrin-dependent mTORC1 signaling and cap-dependent mRNA translation (including cyclin D1); depletion of merlin rescues mTORC1 signaling in anchorage-deprived cells; merlin-negative mesothelioma lines are rapamycin-sensitive; re-expression of merlin confers partial rapamycin resistance.\",\n      \"method\": \"shRNA knockdown, recombinant merlin re-expression, mTORC1 and cap-dependent translation assays, rapamycin sensitivity panel, xenograft models\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — gain- and loss-of-function with biochemical pathway readouts and pharmacological validation, single lab, multiple orthogonal methods\",\n      \"pmids\": [\"19451229\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Erbin, an epithelial-enriched protein, controls merlin tumor suppressor function by switching the functional valence of PAK2 binding: in epithelial cells, Erbin/Merlin complexes bind and inactivate GTPase-bound PAK2, preventing its phosphorylation and inactivation of merlin.\",\n      \"method\": \"Co-immunoprecipitation, TGF-β signaling assays in epithelial vs. mesenchymal cells, PAK2 kinase assays, dominant-negative constructs\",\n      \"journal\": \"Developmental cell\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — Co-IP and kinase assays, single lab, novel binding mechanism described\",\n      \"pmids\": [\"19289088\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"In Nf2-deficient liver, overproliferation of liver progenitors is driven by aberrant EGFR activity; pharmacologic inhibition of EGFR blocks proliferation of Nf2-/- liver progenitors in vitro and in vivo; Merlin was found NOT to be a major regulator of YAP in liver progenitors in this context.\",\n      \"method\": \"Liver-specific conditional Nf2 knockout mouse, EGFR inhibitor treatment in vitro and in vivo, molecular pathway analysis\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — conditional KO with pharmacologic rescue, multiple readouts, single lab\",\n      \"pmids\": [\"20675406\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Rac1 controls Schwann cell myelination through NF2/merlin: Rac1 knockout reduces PAK phosphorylation and NF2/merlin phosphorylation; mutation of NF2/merlin rescues the myelin deficit in Rac1-CKO mice; cAMP levels and E-cadherin expression downstream of Rac1 are restored by NF2/merlin mutation.\",\n      \"method\": \"Rac1 conditional knockout mice, in vivo NF2 mutant rescue experiment, cAMP measurement, E-cadherin immunostaining, rolipram treatment\",\n      \"journal\": \"The Journal of neuroscience : the official journal of the Society for Neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic epistasis (Rac1-CKO rescued by NF2 mutation in vivo), multiple orthogonal readouts\",\n      \"pmids\": [\"23197717\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Merlin restricts the cortical distribution of the actin regulator Ezrin; in the absence of Merlin, ectopic cortical Ezrin yields mispositioned centrosomes, misoriented spindles, and aberrant epithelial architecture; in tumor cells with centrosome amplification, failure to restrict cortical Ezrin abolishes centrosome clustering, causing multipolar mitoses.\",\n      \"method\": \"Nf2-/- epithelial cells, live imaging, centrosome positioning assay, 3D organotypic cultures, spindle orientation analysis\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic KO with defined cellular phenotype, live imaging, multiple functional readouts, single lab\",\n      \"pmids\": [\"23249734\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Nf2/Merlin is required upstream of Lats1/2-dependent YAP phosphorylation in the preimplantation embryo; injection of dominant-negative Nf2 causes YAP mislocalization and ectopic Cdx2 expression, rescued by Lats2 kinase overexpression; maternal-zygotic Nf2 mutant embryos fail to establish a pluripotent ICM and form excess TE.\",\n      \"method\": \"Dominant-negative Nf2 mRNA injection, Lats2 overexpression rescue, maternal-zygotic Nf2 mutant blastocysts, immunofluorescence for YAP and Cdx2\",\n      \"journal\": \"Current biology : CB\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic epistasis (dominant-negative rescued by Lats2), maternal-zygotic KO, multiple readouts, single lab\",\n      \"pmids\": [\"23791728\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Crystal structures show that the Lats1/2-binding site on the Merlin FERM domain is physically blocked by Merlin's auto-inhibitory tail; angiomotin binding releases this auto-inhibition and promotes Merlin binding to Lats1/2; S518 phosphorylation prevents angiomotin from binding Merlin; cancer-causing mutations in the angiomotin-binding domain impair angiomotin-mediated Merlin activation.\",\n      \"method\": \"High-resolution crystal structures of Merlin FERM domain, binding assays, phospho-mimetic/deficient mutants, cancer mutation analysis\",\n      \"journal\": \"Cell research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — crystal structures plus mutagenesis and binding assays, mechanistic model with functional validation\",\n      \"pmids\": [\"26045165\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Merlin and Ezrin are essential components of a mechanism whereby mechanical forces associated with cell-cell junction establishment are transduced via cortical actomyosin to control lateral mobility and activity of EGFR; Merlin inhibits EGFR internalization in a contact-dependent manner requiring cortical cytoskeleton localization.\",\n      \"method\": \"Fluorescence recovery after photobleaching (FRAP), single-particle tracking, Merlin/Ezrin depletion, live imaging, cortical actomyosin perturbation\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct localization experiments (FRAP, SPT) tied to functional EGFR mobility/signaling, multiple orthogonal methods, single lab\",\n      \"pmids\": [\"26483553\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Merlin inhibits Wnt/β-catenin signaling by directly binding LRP6 and blocking LRP6 phosphorylation required for Wnt signal transduction; Wnt3a treatment activates PAK1 in a PIP2-dependent manner, phosphorylating Merlin at S518, causing dissociation from LRP6 and allowing LRP6 phosphorylation.\",\n      \"method\": \"Co-immunoprecipitation, LRP6 phosphorylation assays, PAK1 inhibitor/overexpression, PIP2 manipulation, NF2 patient tissue analysis\",\n      \"journal\": \"Cell death and differentiation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — Co-IP and signaling assays, single lab\",\n      \"pmids\": [\"27285107\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Merlin triggers AMOTL1 proteasomal degradation mediated by NEDD family ubiquitin ligases through direct interaction with AMOTL1.\",\n      \"method\": \"Co-immunoprecipitation, proteasome inhibitor treatment, ubiquitination assays\",\n      \"journal\": \"Neoplasia (New York, N.Y.)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — Co-IP and ubiquitination assay, single lab\",\n      \"pmids\": [\"26806348\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Merlin regulates NF2/Merlin-Lin28B-let-7 tumor-suppressive signaling in a Hippo-independent, cell-density-dependent manner: at high cell density, dephosphorylated Merlin sequesters Lin28B in the cytoplasm permitting pri-let-7 miRNA maturation; at low density, phosphorylated Merlin does not bind Lin28B, allowing nuclear Lin28B to inhibit let-7 maturation.\",\n      \"method\": \"Co-immunoprecipitation, cell density manipulation, phospho-mimetic merlin mutants, miRNA processing assays, Lin28B localization\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — Co-IP and functional miRNA assays, single lab\",\n      \"pmids\": [\"26997273\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"NF2 and Lats1/2 are required for branching morphogenesis in the mouse kidney ureteric bud; removal of Nf2 or Lats1/2 causes loss of branching, rescued by loss of one copy of Yap/Taz; YAP suppresses RET signaling and tip identity downstream of NF2.\",\n      \"method\": \"Conditional knockout mice (ureteric bud lineage), genetic epistasis (Yap/Taz heterozygous rescue), mosaic analysis\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic epistasis with conditional KO and heterozygous rescue, in vivo, multiple readouts\",\n      \"pmids\": [\"27480037\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"In Drosophila, Merlin and Kibra activate Hippo signaling in parallel to Expanded at a spatially distinct cellular domain (medial apical cortex); Merlin and Kibra together recruit Salvador, which recruits the core kinase Hippo.\",\n      \"method\": \"Drosophila genetics, live imaging, domain-specific immunofluorescence, epistasis analysis\",\n      \"journal\": \"Developmental cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic epistasis and subcellular localization with functional consequences, single lab\",\n      \"pmids\": [\"28292426\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"In epithelial cells, E-cadherin-mediated intercellular contact suppresses ferroptosis by activating intracellular NF2 and Hippo signaling; YAP (when NF2/Hippo is inactive) promotes ferroptosis by upregulating ACSL4 and TFRC; NF2 genetic inactivation renders cancer cells more sensitive to ferroptosis.\",\n      \"method\": \"NF2 genetic inactivation (siRNA and KO), E-cadherin blocking antibodies, ferroptosis assays (lipid peroxidation), YAP reporter assays, orthotopic mouse model\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple genetic and pharmacologic tools, in vitro and in vivo, multiple orthogonal functional readouts\",\n      \"pmids\": [\"31341276\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"NF2/Merlin regulates TEAD palmitoylation and stability in a cell-density-dependent manner; Merlin suppresses fatty acid synthase (FASN) and acetyl-CoA carboxylase (ACC) expression (involved in de novo palmitate biosynthesis), leading to TEAD depalmitoylation by APT2/ABHD17A and subsequent proteasomal degradation via E3 ligase CHIP.\",\n      \"method\": \"NF2 knockdown/overexpression, FASN/ACC expression assays, palmitoylation assays, proteasome inhibitor treatment, TEAD stability assays\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — multiple biochemical assays, single lab, novel pathway\",\n      \"pmids\": [\"31043565\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"BRCA1/BARD1 ubiquitinates NF2, leading to NF2 destabilization, which turns off the Hippo pathway and stabilizes YAP1; in BRCA1-deficient cells the Hippo pathway is activated.\",\n      \"method\": \"BRCA1 knockout cells, co-immunoprecipitation, ubiquitination assay, YAP1 phosphorylation assays, YAP1 mutant (5SA) rescue\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — ubiquitination assay and KO with pathway readout, single lab\",\n      \"pmids\": [\"30918126\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"NF2's lipid-binding ability is required for Hippo pathway activation in response to osmotic stress; osmotic stress induces PI(4,5)P2 plasma membrane enrichment via PIP5K family activation, allowing NF2 membrane recruitment and downstream LATS/YAP phosphorylation; NF2 mutant deficient in lipid binding cannot activate the Hippo pathway.\",\n      \"method\": \"NF2 lipid-binding mutant, PIP5K manipulation, PI(4,5)P2 measurement, LATS and YAP phosphorylation assays under osmotic stress\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — mutagenesis of lipid-binding domain with biochemical pathway readouts, lipid manipulation, single lab with multiple orthogonal methods\",\n      \"pmids\": [\"32115406\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"NEDD4L-mediated ubiquitination of Merlin at lysine 396 is required to activate Merlin in the Hippo pathway; ubiquitination is promoted by S518 dephosphorylation; AMOTL1 scaffolds NEDD4L to Merlin; ubiquitinated Merlin binds Lats1 and activates Lats1; the K396R mutation or NEDD4L depletion disrupts Lats1 binding and activation and abolishes anti-mitogenic activity.\",\n      \"method\": \"Ubiquitination assays, NEDD4L overexpression/depletion, Merlin K396R mutant, Lats1 binding assays, anti-mitogenic functional assays, NF2-patient mutation analysis\",\n      \"journal\": \"EMBO reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in-cell ubiquitination assay with mutagenesis and functional rescue, multiple orthogonal methods, single lab\",\n      \"pmids\": [\"33058421\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"In Drosophila epithelia, Merlin forms solid-like condensates at the medial apical cortex (distinct from cell junctions); condensate formation requires phosphatidylinositol-4-phosphate (PI4P)-mediated plasma membrane targeting and is antagonistically controlled by Pez and cytoskeletal tension through PI4P regulation; solid-like material properties of Merlin condensates are essential for Hippo pathway activation.\",\n      \"method\": \"Drosophila live imaging, PI4P manipulation, condensate biophysical characterization, genetic manipulation of Pez and cytoskeletal tension\",\n      \"journal\": \"Science (New York, N.Y.)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — structural/biophysical condensate characterization combined with genetic manipulation and functional pathway assay, single lab\",\n      \"pmids\": [\"39116228\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"Merlin isoform I and isoform II both interact with ezrin through a head-to-tail orientation (N-terminal half of one protein with C-terminal half of the other); isoform I binds only open-conformation ezrin while isoform II binds regardless of conformation; merlin homodimerization is stronger than merlin-ezrin interaction and can inhibit merlin-ezrin binding.\",\n      \"method\": \"Co-immunoprecipitation, yeast two-hybrid assays, domain-mapping experiments\",\n      \"journal\": \"Journal of neuroscience research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — Co-IP and yeast two-hybrid with domain mapping, single lab\",\n      \"pmids\": [\"11070492\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Layilin (a cell-surface hyaluronan receptor) interacts with full-length merlin and its N-terminal FERM domain independently of phospholipids; layilin antibody can co-immunoprecipitate merlin, confirming in vivo association; both proteins show similar subcellular localization in ruffling membranes.\",\n      \"method\": \"Co-immunoprecipitation, GST-pulldown assays, immunofluorescence colocalization\",\n      \"journal\": \"Experimental cell research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Weak — Co-IP and pulldown with colocalization, single lab\",\n      \"pmids\": [\"15913605\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Schwannomin/merlin and HRS (hepatocyte growth factor-regulated tyrosine kinase substrate) cooperatively inhibit Stat3 and Stat5 activation; a pathogenic missense mutation Q538P in schwannomin fails to bind HRS and does not inhibit Stat5 phosphorylation.\",\n      \"method\": \"Co-immunoprecipitation, STAT phosphorylation assays, schwannomin mutant (Q538P), IGF-I stimulation in human schwannoma cells\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — Co-IP and signaling assays with mutant validation, single lab\",\n      \"pmids\": [\"12444102\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Merlin phosphorylation at S518 affects its interaction with tubulin: merlin's intramolecular association and S518 phosphorylation regulate the merlin-tubulin interaction; merlin promotes tubulin polymerization in vitro.\",\n      \"method\": \"In vitro tubulin polymerization assay, phospho-mimetic/deficient merlin mutants, primary Schwann cells from merlin-deficient mice\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Weak — in vitro polymerization reconstitution with mutagenesis, single lab\",\n      \"pmids\": [\"17566081\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Merlin inhibits neurite outgrowth through a mechanism dependent on S518 phosphorylation and involving inactivation of Rac GTPase; overexpression of merlin in cerebellar cultures and P19 neurogenic cells decreases neurite outgrowth; merlin inhibition increases process formation.\",\n      \"method\": \"Merlin overexpression/knockdown in cerebellar cultures and P19 cells, S518 phosphorylation mutants, neurite length quantification\",\n      \"journal\": \"The Journal of neuroscience : the official journal of the Society for Neuroscience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — gain- and loss-of-function with phospho-mutants, single lab\",\n      \"pmids\": [\"20668201\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Akt phosphorylates merlin at T230 and S315; this phosphorylation abolishes merlin's folded conformation, inhibits its association with PIKE-L, promotes merlin polyubiquitination, and leads to proteasome-mediated degradation, providing a negative feedback loop from merlin/PIKE-L/PI3K to Akt.\",\n      \"method\": \"In vitro Akt kinase assay, phospho-site mutagenesis, co-immunoprecipitation, ubiquitination assay, proteasome inhibitor treatment\",\n      \"journal\": \"Cell adhesion & migration\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Weak — kinase assay with mutagenesis and degradation assay, single lab\",\n      \"pmids\": [\"19262146\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"Calpain (a calcium-dependent cysteine protease) cleaves and degrades merlin; marked calpain system activation results in merlin degradation in some schwannomas and meningiomas lacking NF2 mutations.\",\n      \"method\": \"Calpain cleavage assays, tumor tissue analysis for calpain activity and merlin levels\",\n      \"journal\": \"Neuropathology : official journal of the Japanese Society of Neuropathology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — biochemical cleavage assay and tumor tissue analysis, single lab\",\n      \"pmids\": [\"11132929\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Merlin-deficient cells show increased dependence on FAK signaling (synthetic lethal relationship); weak cell-cell adhesions in Merlin-negative MPM cells underlie greater dependence on cell-ECM-induced FAK signaling, explaining FAK inhibitor vulnerability.\",\n      \"method\": \"Cancer cell line panel, cell-cell/ECM contact blocking antibodies, FAK inhibitor (VS-4718) sensitivity assays, xenograft models\",\n      \"journal\": \"Science translational medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — pharmacologic and genetic dependency mapping, single lab\",\n      \"pmids\": [\"24848258\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Merlin suppresses FOXM1 protein stability, which plays a critical role in nuclear translocation of β-catenin; by destabilizing FOXM1, Merlin suppresses Wnt/β-catenin signaling and downstream target gene expression.\",\n      \"method\": \"Merlin overexpression/knockdown, FOXM1 protein stability assays, β-catenin nuclear localization, FOXM1 overexpression rescue\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — gain- and loss-of-function with rescue experiment, single lab\",\n      \"pmids\": [\"26483206\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"NF2/merlin re-expression in schwannoma cells inhibits cell proliferation under serum-free conditions; merlin accelerates PDGFR internalization, inhibits PDGF-induced MAPK and PI3K signaling (pErk1/2, pAkt), and promotes PDGFR degradation.\",\n      \"method\": \"Adenoviral NF2 overexpression in HEI193 schwannoma cells, proliferation assays, receptor internalization assay, Western blotting for signaling\",\n      \"journal\": \"International journal of oncology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — gain-of-function with receptor trafficking and signaling readouts, single lab\",\n      \"pmids\": [\"14612918\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Merlin/NF2 regulates angiogenesis in schwannomas through Rac1; loss of merlin downregulates semaphorin 3F (SEMA3F) expression through Rac1; re-introduction of SEMA3F normalized tumor blood vessels and reduced tumor burden in vivo.\",\n      \"method\": \"RNA interference, chemical inhibitors for Rac1, SEMA3F re-expression in NF2-null cells, intracranial tumor models in nude mice\",\n      \"journal\": \"Neoplasia (New York, N.Y.)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — RNAi and rescue with in vivo validation, single lab\",\n      \"pmids\": [\"22431917\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"Merlin (NF2) is a FERM-domain tumor suppressor that functions at both the cell cortex and in the nucleus: at the cortex, it links membrane receptors (EGFR, PDGFR) and adhesion molecules to the cortical actomyosin cytoskeleton, restricting receptor mobility/internalization and inhibiting downstream Rac/PAK, FAK/Src, PI3K/Akt, Ras/MAPK, mTORC1, and Wnt/LRP6 signaling cascades; its activity is tightly regulated by phosphorylation at S518 (by PAK1/2, downstream of Rac/Cdc42, inactivating merlin) and dephosphorylation (activating merlin), and by ubiquitination (NEDD4L at K396, activating merlin for Hippo signaling) and Akt-mediated phosphorylation (T230/S315, promoting proteasomal degradation); merlin adopts an auto-inhibited closed conformation that is relieved by angiomotin binding to enable Lats1/2 binding and Hippo pathway activation, and at the medial apical cortex forms solid-like PI4P-dependent condensates that further activate Hippo signaling; in the nucleus, merlin directly inhibits the CRL4(DCAF1) E3 ubiquitin ligase to suppress oncogenic gene expression; collectively, these mechanisms mediate contact-dependent inhibition of proliferation, cell polarity, and suppression of tumorigenesis.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"Merlin (NF2) is a FERM-domain tumor suppressor that couples cell-cell contact and cortical cytoskeletal organization to the restraint of mitogenic signaling and proliferation [#3, #17]. At the cortex, merlin associates with adherens-junction components and is required for contact-dependent growth arrest and stable junction assembly [#3], and it transduces junctional mechanical force through cortical actomyosin to restrict the lateral mobility and internalization of EGFR [#17]; it likewise accelerates PDGFR internalization and degradation while dampening MAPK and PI3K output [#38], and inhibits PI3K via PIKE-L [#4] and integrin-driven mTORC1 signaling [#10]. Merlin activity is governed by a conformational switch and a dense phosphorylation/ubiquitination code: PAK, downstream of Rac/Cdc42, directly phosphorylates merlin at S518 to inactivate it [#1, #2], and the S518-phosphomimetic form fails to suppress growth and motility [#5], whereas dephosphorylation and NEDD4L-mediated ubiquitination at K396 — scaffolded by AMOTL1 — activate merlin for Lats1 binding and anti-mitogenic function [#27]. Structurally, an auto-inhibitory tail occludes the Lats1/2-binding surface of the FERM domain, and angiomotin binding relieves this auto-inhibition to drive Hippo pathway activation, an event blocked by S518 phosphorylation [#16]. Merlin acts upstream of Lats1/2-dependent YAP phosphorylation to control cell fate and morphogenesis in vivo [#15, #21], requires lipid (PI(4,5)P2/PI4P) binding for membrane recruitment and Hippo activation [#26], and forms PI4P-dependent solid-like condensates at the medial apical cortex essential for Hippo signaling [#28]. Through this Hippo/YAP axis merlin also controls contact-dependent ferroptosis, with NF2 loss sensitizing cancer cells to ferroptosis [#23]. Beyond canonical Hippo signaling, merlin restricts cortical Ezrin to ensure correct centrosome positioning and spindle orientation [#14] and inhibits Wnt/\\u03b2-catenin signaling by binding LRP6 and blocking its phosphorylation [#18].\"\n  ,\n  \"teleology\": [\n    {\n      \"year\": 2001,\n      \"claim\": \"Established that merlin sits in a Rac-PAK signaling axis and that its activity is controlled by phosphorylation, defining the upstream regulation of the tumor suppressor.\",\n      \"evidence\": \"Nf2-/- mouse cells, activated Rac expression and phosphorylation assays, plus in vitro/in vivo PAK kinase assays identifying S518\",\n      \"pmids\": [\"11703924\", \"11719502\", \"11782491\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not establish how S518 phosphorylation alters merlin's downstream effectors at the molecular level\", \"Phosphatase(s) reactivating merlin not identified\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Linked merlin to contact-dependent growth arrest by showing it is required for adherens-junction assembly, connecting the molecule to a defined cellular phenotype.\",\n      \"evidence\": \"Nf2-/- primary cells with colocalization and co-IP against AJ components\",\n      \"pmids\": [\"12695331\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct molecular partner within the junction not pinned down\", \"Mechanism connecting AJ assembly to growth arrest left open\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Connected merlin to growth-factor receptor signaling by showing it inhibits PI3K through PIKE-L and that S518 phosphorylation abrogates growth/motility suppression.\",\n      \"evidence\": \"PI3K activity assays, PIKE-L mutant and RNAi, plus inducible phosphomimetic S518D/S518A merlin in schwannoma cells\",\n      \"pmids\": [\"15598747\", \"14724586\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Relative contribution of PIKE-L vs other effectors to tumor suppression unresolved\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Showed merlin restrains FAK/Src/PI3K signaling and receptor trafficking, broadening its role to multiple oncogenic cascades and receptor clearance.\",\n      \"evidence\": \"Merlin re-expression in mesothelioma cells with FAK/Src/p85 co-IP; Drosophila Mer;ex double-mutant pulse-chase receptor trafficking\",\n      \"pmids\": [\"16652148\", \"16581517\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether receptor clearance is the primary tumor-suppressive output not established\", \"Direct vs indirect effect on FAK phosphorylation unclear\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Defined merlin's interaction with the microtubule cytoskeleton, extending its cortical role to tubulin polymerization regulated by conformation and S518.\",\n      \"evidence\": \"In vitro tubulin-binding/polymerization assays, domain and phospho-mutants, merlin-deficient Schwann cells\",\n      \"pmids\": [\"17566081\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Functional consequence of merlin-microtubule binding for tumor suppression not defined\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Connected merlin loss to integrin-driven mTORC1 activation and rapamycin sensitivity, identifying a druggable downstream dependency.\",\n      \"evidence\": \"shRNA and re-expression with mTORC1/cap-dependent translation readouts and rapamycin panel plus xenografts\",\n      \"pmids\": [\"19451229\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular step linking merlin to mTORC1 not resolved\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Demonstrated tissue-context specificity by showing Nf2-driven liver progenitor overgrowth is EGFR-driven and YAP-independent, cautioning against a single universal effector.\",\n      \"evidence\": \"Liver-specific conditional Nf2 knockout with EGFR inhibitor rescue\",\n      \"pmids\": [\"20675406\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Why YAP is dispensable here but central elsewhere is unexplained\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Showed merlin restricts cortical Ezrin to control centrosome positioning and spindle orientation, and that Rac1-merlin signaling governs Schwann cell myelination in vivo.\",\n      \"evidence\": \"Nf2-/- epithelial cells with live imaging/spindle assays; Rac1-CKO rescued by NF2 mutation in vivo\",\n      \"pmids\": [\"23249734\", \"23197717\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanistic basis of cortical Ezrin exclusion by merlin only partly defined\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Placed Nf2/Merlin genetically upstream of Lats1/2-YAP in cell-fate determination, cementing its role in the core Hippo pathway during development.\",\n      \"evidence\": \"Dominant-negative Nf2 with Lats2 rescue and maternal-zygotic Nf2 mutant blastocysts\",\n      \"pmids\": [\"23791728\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How merlin physically engages the Lats kinases not addressed in this study\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Provided the structural mechanism: an auto-inhibitory tail blocks Lats1/2 binding and angiomotin relieves this auto-inhibition, with S518 phosphorylation and cancer mutations disrupting activation.\",\n      \"evidence\": \"Crystal structures of the Merlin FERM domain with binding assays, phospho- and cancer-mutant analysis\",\n      \"pmids\": [\"26045165\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo dynamics of the open/closed transition not directly visualized\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Tied junctional mechanical force to EGFR mobility/internalization via Merlin and Ezrin, and identified FAK dependency as a therapeutic vulnerability of Merlin-negative tumors.\",\n      \"evidence\": \"FRAP/single-particle tracking of EGFR with Merlin/Ezrin depletion; FAK inhibitor sensitivity in cell panels and xenografts\",\n      \"pmids\": [\"26483553\", \"24848258\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanochemical step linking cortical actomyosin to receptor confinement not fully resolved\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Showed Merlin's Hippo control extends to in vivo organ morphogenesis and revealed Hippo-independent (Lin28B-let-7) and density-dependent outputs.\",\n      \"evidence\": \"Conditional kidney KO with Yap/Taz heterozygous rescue; co-IP and miRNA processing assays with phospho-merlin mutants\",\n      \"pmids\": [\"27480037\", \"26997273\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Relative weight of Hippo-dependent vs -independent outputs in tumor suppression unknown\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Connected contact-dependent NF2/Hippo signaling to ferroptosis sensitivity, identifying NF2 loss as a determinant of ferroptosis vulnerability.\",\n      \"evidence\": \"NF2 inactivation, E-cadherin blocking, ferroptosis and YAP reporter assays, orthotopic mouse model\",\n      \"pmids\": [\"31341276\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Generality across NF2-mutant tumor types not established\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Defined lipid binding as a requirement for Merlin membrane recruitment and Hippo activation under osmotic stress, mechanistically anchoring Merlin to the plasma membrane.\",\n      \"evidence\": \"Lipid-binding mutant, PIP5K manipulation, PI(4,5)P2 measurement, LATS/YAP phosphorylation assays\",\n      \"pmids\": [\"32115406\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How lipid binding integrates with conformational opening not fully resolved\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Resolved the activating ubiquitination event: NEDD4L modifies Merlin at K396 (AMOTL1-scaffolded, dephosphorylation-dependent) to enable Lats1 binding and anti-mitogenic activity.\",\n      \"evidence\": \"Ubiquitination assays, K396R mutant, NEDD4L depletion, Lats1 binding and functional rescue, patient mutation analysis\",\n      \"pmids\": [\"33058421\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Integration of K396 ubiquitination with the angiomotin-mediated conformational switch not directly tested\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Showed Merlin forms PI4P-dependent solid-like condensates at the medial apical cortex whose material properties are essential for Hippo activation, adding a biophysical layer to its mechanism.\",\n      \"evidence\": \"Drosophila live imaging, PI4P manipulation, condensate biophysical characterization, Pez/tension perturbation\",\n      \"pmids\": [\"39116228\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether mammalian Merlin forms comparable condensates not demonstrated\", \"Molecular composition of the condensate beyond Merlin/PI4P undefined\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How the multiple regulatory layers — conformational auto-inhibition, S518 phosphorylation, K396 ubiquitination, lipid binding, and condensate formation — are integrated into a single activation hierarchy in mammalian cells remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No unified model ordering the regulatory inputs\", \"Tissue-specific selection of effector pathways (Hippo vs EGFR vs mTORC1) not mechanistically explained\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0008092\", \"supporting_discovery_ids\": [8, 14, 17, 32]},\n      {\"term_id\": \"GO:0060089\", \"supporting_discovery_ids\": [16, 26, 27]},\n      {\"term_id\": \"GO:0008289\", \"supporting_discovery_ids\": [26, 28]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [4, 18, 27]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [17, 26, 28]},\n      {\"term_id\": \"GO:0005856\", \"supporting_discovery_ids\": [0, 8, 14, 17]},\n      {\"term_id\": \"GO:0005815\", \"supporting_discovery_ids\": [14]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [15, 16, 21, 22, 26, 27]},\n      {\"term_id\": \"R-HSA-1500931\", \"supporting_discovery_ids\": [3, 17, 23]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [15, 21]},\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [23]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"EZR\", \"PAK2\", \"AMOTL1\", \"LATS1\", \"PIKE-L\", \"LRP6\", \"NEDD4L\", \"ERBIN\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":7,"faith_total":7,"faith_pct":100.0}}